Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

[Surgical treatment of sclerosing hepatocellular carcinoma]

[Surgical treatment of sclerosing hepatocellular carcinoma] Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • [Surgical treatment of sclerosing hepatocellular carcinoma] Abstract Text:

    bum-soo kimBum-Soo Kim,sung-gyu leeSung-Gyu Lee,shin hwangShin Hwang,young-joo leeYoung-Joo Lee,kwang-min parkKwang-Min Park,ki-hun kimKi-Hun Kim,chul-soo ahnChul-Soo Ahn,deok-bog moonDeok-Bog Moon,tae-yong haTae-Yong Ha,gi-won songGi-Won Song,dong-hwan jungDong-Hwan Jung,ki-myung moonKi-Myung Moon,

    BACKGROUND/AIMS: Sclerosing hepatocellular carcinoma (HCC) is an unusual subtype of HCC that is characterized by an embedded dense fibrous stroma in the tubular neoplastic structures. We aimed to assess the surgical approaches and outcomes of sclerosing HCC. METHODS: We retrospectively analyzed the clinicopathologic features of 6 patients with sclerosing HCC who underwent surgical treatment at Asan Medical Center between July 1989 and December 2005. RESULTS: Six HCC patients with sclerosing HCC were diagnosed out of the total 1390 HCC patients (0.43%) during the study period. The mean age was 58 years and 4 patients were male. Weight loss and abdominal pain were the most common symptoms. The serum calcium and phosphorus levels were normal in all the patients. All of them were hepatitis B surface antigen-positive, but none was positive for hepatitis C. All the lesions were solitary. The tumor size ranged from 45 to 150 mm in diameter (median size: 81 mm). We performed right trisegmentectomy (n=1), central bisegmentectomy (n=1), right anterior segmentectomy (n=1), ex-vivo resection and autotransplantation (n=1) and right posterior segmentectomy (n=2). The median overall survival and disease free-survival periods were 24 months and 9.5 months, respectively. CONCLUSIONS: The incidence of sclerosing HCC was very low. Sclerosing HCC was often not correctly diagnosed before an operation, but performing resection prolonged the patients' survival and their prognosis was not worse than that for ordinary HCC. Our experience implicates that aggressive surgical treatment for sclerosing HCC is beneficial for patient survival.

    [Surgical treatment of sclerosing hepatocellular carcinoma] Publishing Authors By Initials

    bs kimBS Kim,sg leeSG Lee,s hwangS Hwang,yj leeYJ Lee,km parkKM Park,kh kimKH Kim,cs ahnCS Ahn,db moonDB Moon,ty haTY Ha,gw songGW Song,dh jungDH Jung,km moonKM Moon,

    For similar abstracts research abstracts see: abstracts research

    PUBMED ID PMID:

    MEDLINE DATE:

    [Surgical treatment of sclerosing hepatocellular carcinoma] Journal Published:

    PUBLICATION TYPE: Journal Article

    Journal: The Korean journal of hepatology

    VOLUME: 12

    Page Numbers: 412-9

    Journal Abbreviation:

    ISSN: 1738-222X

    DAY: 25

    MONTH: Sep

    YEAR: 2006

    [Surgical treatment of sclerosing hepatocellular carcinoma] Information

    Number of References:

    LANGUAGE: kor

    NlmUniqueID: 101211947

    [Surgical treatment of sclerosing hepatocellular carcinoma] Keywords Mesh Terms:

    KEYWORDS:

    MESH TERMS:

    Chemical & Substance for Abstract: [Surgical treatment of sclerosing hepatocellular carcinoma] Information

    Substance Name:

    Registry Number:

    Grant and Affiliation Information for [Surgical treatment of sclerosing hepatocellular carcinoma]

    AFFILIATION: Division of Hepatobiliary Surgery and Liver Transplantation, Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.

    Country: Korea (South)

    Korea (South) Research PublicationKorea (South) Research Publication

    AGENCY:

    GRANT:

    ACRONYM:

    MEDLINETA: Korean J Hepatol

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Surgical treatment of sclerosing hepatocellular carcinoma Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News